Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, Rodés J
Hormonal Laboratory, Hospital Clínic i Provincial, University of Barcelona, Spain.
Hepatology. 1992 Feb;15(2):343-9. doi: 10.1002/hep.1840150227.
Nitric oxide is a vasodilator tonically secreted by endothelial cells that is involved in the regulation of arteriolar tone. This study, which includes two protocols, was performed to investigate whether nitric oxide plays a role in the pathogenesis of arterial hypotension in cirrhosis with ascites. In protocol 1, the administration of increasing doses (25, 50, 250, 500 and 1,000 micrograms.kg-1.min-1) of the nitric oxide biosynthesis inhibitor N omega-nitro-L-arginine to 18 conscious rats with cirrhosis and ascites produced, at each dose tested, a significantly greater increase in arterial pressure than in 17 conscious control rats. At the lowest dose of N omega-nitro-L-arginine, arterial pressure significantly rose in cirrhotic rats but not in controls. In protocol 2, arterial pressure, estimated renal plasma flow, glomerular filtration rate and sodium excretion were measured in 12 cirrhotic rats with ascites and 10 control rats before and during the sequential infusion of previously selected doses of N omega-nitro-L-arginine (25, 50 and 250 micrograms.kg-1.min-1). Changes in arterial pressure reproduced those observed in protocol 1. In control rats, N omega-nitro-L-arginine caused a decrease in estimated renal plasma flow without affecting glomerular filtration rate or sodium excretion. In contrast, N omega-nitro-L-arginine administration to cirrhotic animals did not produce any appreciable renal vasoconstrictor effect, and it increased glomerular filtration rate and sodium excretion.(ABSTRACT TRUNCATED AT 250 WORDS)
一氧化氮是一种由内皮细胞持续分泌的血管舒张剂,参与小动脉张力的调节。本研究包括两个方案,旨在探讨一氧化氮是否在肝硬化腹水患者动脉低血压的发病机制中起作用。在方案1中,给18只清醒的肝硬化腹水大鼠注射递增剂量(25、50、250、500和1000微克·千克⁻¹·分钟⁻¹)的一氧化氮生物合成抑制剂Nω-硝基-L-精氨酸,在每个测试剂量下,肝硬化大鼠的动脉压升高幅度均显著大于17只清醒对照大鼠。在最低剂量的Nω-硝基-L-精氨酸时,肝硬化大鼠的动脉压显著升高,而对照大鼠则无此现象。在方案2中,在12只肝硬化腹水大鼠和10只对照大鼠中,在连续输注先前选定剂量的Nω-硝基-L-精氨酸(25、50和250微克·千克⁻¹·分钟⁻¹)之前和期间,测量动脉压、估计肾血浆流量、肾小球滤过率和钠排泄。动脉压的变化重现了方案1中观察到的情况。在对照大鼠中,Nω-硝基-L-精氨酸导致估计肾血浆流量减少,而不影响肾小球滤过率或钠排泄。相反,给肝硬化动物注射Nω-硝基-L-精氨酸并未产生明显的肾血管收缩作用,反而增加了肾小球滤过率和钠排泄。(摘要截断于250字)